A special set of sugars found on some disease-causing pathogens helps those pathogens fight the body's natural defenses as well as vaccines, say two Iowa State University researchers. This discovery may be a first step in understanding a disease family that includes tuberculosis for which there are currently no good vaccines or cures.
Nicola Pohl, professor of chemistry, and Christine Petersen, assistant professor of veterinary pathology, discovered that a natural coating of sugar interacts with the body's defense cells to dampen its own immune response. Their findings are published in the current online issue of the Journal of the American Chemical Society.
Pohl and Petersen began studying persistent pathogens such as tuberculosis and the parasite Leishmania five years ago when they noticed that some types of the parasite can make people sick, while others do not.
"One of the things I was curious about was that pathogenic strains of Leishmania have a different sugar coating on them than nonpathogenic strains," Pohl said. "We asked the question 'Is it possible that just the sugar coating is enough to make something pathogenic or nonpathogenic?'"
Leishmania-associated diseases are not usually found in the United States, but have been observed in soldiers returning from the Middle East. The diseases can cause unsightly sores, and can last a period of months, according to Pohl. The diseases are often fatal to dogs in the United States.
"The problem is, in places like Bangladesh, where people are in a nutritionally compromised state, peoples' immune systems aren't strong enough, and the disease can be fatal," said Pohl.
Normally, when a disease-causing agent enters the body, cells called macrophages engulf and start to destroy the agent. Leishmania-type diseases are resistant to this process.
To test the theory on the resistance effect of the sugar coating, Pohl and Petersen developed an experiment that required creating small beads measuring one micron in diameter to mimic the pathogens. One group of beads was then coated with a type of sugar that is similar to that of Leishmania. Another set of beads was coated with a lactose-type sugar that isn't harmful to the cell. A third had no coating. The beads were then introduced into macrophages.
When the uncoated beads were introduced into the macrophages, the cells noticed the beads and started an immune response, as they should. When the lactose-covered beads were introduced, they were also recognized and removed. When the Leishmania-sugar covered beads were introduced, the macrophages took a much longer time to recognize their presence. Then, the immune defense system slowed down or dampened the attacks. This dampening, Petersen and Pohl showed, is due to an interaction between the sugar on the bead and Toll-like receptor2 (TLR2) within the macrophage.
"There is something inherent about the sugars themselves, and the difference in these sugars, that dampens your normal response to the pathogen," said Pohl. Pohl said they don't yet know exactly what that interaction is or how it works, but she hopes that this research may lead to more research eventually beating the disease. "Right now we don't have good therapeutics against Leishmaniasis, and we don't have a vaccine for it, so basically you can't do anything about it," she added. "The more information we have about this, the more we learn about how to circumvent this to get an effective vaccine," she said.
Petersen credits the partnership with Pohl as one of the key factors in understanding the problem. Pohl's chemistry background doesn't often lead her to look at whole organisms and Petersen, as a veterinary pathologist, previously didn't look at the chemistry.
"Many of these critical sub-molecular interactions are often glossed over by immunologists and biologists," said Petersen. "But the work Nikki and I just published shows that they can make a much larger difference in how a pathogen is sensed by the immune system."
The research staff also included Alex Osanya, an assistant scientist in veterinary pathology and Eun-Ho Song, a former graduate student in chemistry.
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses' (AORN’s) International Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
How To Optimize Your Time Management Strategies for the Busy Infection Preventionist
March 25th 2024Is your calendar resembling a chaotic masterpiece of overlapping tasks? Join the club of infection preventionists striving to balance responsibilities. Dive into proven strategies from a fellow infection preventionist to reclaim control of your time, streamline tasks, and boost productivity effectively. This is an IP Lifeline article.
CenTrak Unveils Revolutionary BLE Multi-Mode Platform for Health Care RTLS Solutions
March 22nd 2024CenTrak, the industry leader in real-time location technology, introduces the groundbreaking BLE Multi-Mode Platform, setting a new standard for Real-Time Location Systems (RTLS) in health care. Discover how this innovative solution enhances location data precision and streamlines operations for health care organizations.